Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from the U.S. Food and Drug Administration (FDA) to initiate an international ...

CellTrans has claimed the first FDA approval for a cell therapy used to treat type 1 diabetes, consisting of insulin-producing islet beta cells taken from deceased donors. The Chicago-based ...

Three lines of GMP iPS Cells derived from type O female ... I Peace's iPSC offerings have been enriched to serve a wider variety of cell therapy developers and pharmaceutical companies.

The deal has been announced just a few days after the FDA lifted a clinical hold on a phase 1/2 trial of VX-880 – a stem cell therapy Vertex acquired through its near $1 billion acquisition of ...

“That data can serve as an input for modeling — for machine learning, expert systems, and training of AI,” he adds. Typically, the primary real-time measurements in cell and gene therapy manufacturing ...

Feb. 4, 2025 — Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in preclinical models tested in mice.

Three lines of GMP iPS Cells derived from type O female blood are now offered as off-the-shelf ... With the offering of these off-the-shelf, low immunoreaction risk iPSCs, I Peace's iPSC offerings ...

According to research by nova one advisor, the global cell and gene therapy market size was valued at $18.13 billion in 2023 and is anticipated to reach around $97.33 billion by 2033, growing at a ...